Leondios Kostrikis

Title: Leondios Kostrikis: Innovator in Genomic Research

Introduction

Leondios Kostrikis is a prominent inventor based in New York, NY (US). He has made significant contributions to the field of genomics, particularly in the identification of genetic sequences that serve as genomic equivalent markers. His work has implications for quantifying cells and polynucleotide sequences, which is crucial in various biological and medical research areas.

Latest Patents

Kostrikis holds a patent titled "Methods for identifying genomic equivalent markers and their use in quantitating cells and polynucleotide sequences therein." This patent describes methods for identifying genetic sequences that are useful as genomic equivalent markers for organisms. The method involves determining the ratio of the absolute number of copies of wild type and mutant amplicons in samples from organisms heterozygous for the mutation. By establishing the number of copies of a particular genetic sequence per genome, researchers can normalize the analysis of another target sequence to abundance per cell. For example, the CCR5 gene was shown to be present at 2 copies per genome, which was used to measure the number of copies per cell of HIV-1 provirions and other important markers.

Career Highlights

Leondios Kostrikis is affiliated with The Rockefeller University, where he conducts his research. His innovative approaches have led to advancements in understanding genetic markers and their applications in health and disease. His work is recognized for its potential to enhance the accuracy of genomic analyses.

Collaborations

Kostrikis has collaborated with notable scientists in the field, including Sharon R. Lewin and David D. Ho. These collaborations have further enriched his research and contributed to the advancement of genomic studies.

Conclusion

Leondios Kostrikis is a key figure in genomic research, with a patent that showcases his innovative methods for identifying genetic sequences. His contributions continue to influence the field and pave the way for future discoveries in genomics.